ºüÀêÊÓƵ

Craig Lindsley, co-director of the Vanderbilt Center for Neuroscience Drug Discovery, has been named a fellow of the National Academy of Inventors.

In one of the largest studies of its kind, an international research team led by 20 Vanderbilt University scientists has discovered more than 200 new genetic variations associated with high blood pressure.

A research team led by Russell Rothman has been approved for a $7 million research funding award from the Patient-Centered Outcomes Research Institute to conduct a trial comparing clinic and consumer information technology approaches to promote healthy behaviors and prevent early childhood obesity.

Boehringer Ingelheim and Vanderbilt Center for Neuroscience Drug Discovery today announced two new global agreements to investigate, develop and commercialize novel small molecules targeting two distinct G-protein coupled receptors known to engage in the modulation of certain brain circuitries, which are altered in neuropsychiatric conditions such as schizophrenia. Read More

Vanderbilt University researchers are working to understand how people with schizophrenia experience emotion through their bodies. Read More

New research led by Rebecca Cook demonstrates that an antiviral receptor called RIG-I has potent immunogenic and therapeutic effects in breast cancer.

A neural mapping approach that pegs results from more than two dozen previous Alzheimer’s studies found that reproducibility improves when trying to isolate symptoms to a brain network rather than a single area of the brain.

A randomized trial by Vanderbilt-Ingram Cancer Center researchers indicates that magnesium optimizes vitamin D status, raising it in people with deficient levels and lowering it in people with high levels.

Vanderbilt School of Medicine and Peabody College have established a transinstitutional Policies for Action Research Hub to better understand and develop recommendations to address the needs of some of Tennessee’s most vulnerable children, including those in immigrant families and with prenatal exposure to opioids.

New research led by Alyssa Hasty shows that diet-induced weight loss in obese individuals increases levels of a white blood cell that promotes metabolic health in fatty tissues, but not in the liver.

Mukhtar Ahmed and colleagues say the methods they employed to understand the mechanisms by which exocysts--protein complexes essential to life--function have the potential to revolutionize our understanding of cell dynamics.

The report authored by Margaret Adgent adds to the increasing evidence supporting the reproductive health consequences of early-life exposure to soy formula.

The grant will support Mary Philip's research to develop an organoid model — a miniature cell model of a functioning organ — of the liver to enable three-dimensional observation of immune-cancer interactions at the single-cell level at the earliest stages of cancer development.

Filling opioid prescriptions after giving birth raises the risk of prolonged use of the drugs in the following year.

New research by John Karijolich and colleagues have found that RNA, not viruses, activate the sentry enzymes that serve as the first line of defense against viruses.

The findings reinforce guidelines for cautious use of antipsychotics in younger populations, according to senior author Wayne Ray.

Research led by James Crowe, Jr., could lead to the first effective treatment for this dangerous mosquito-transmitted infection.

The study will test the safety of a new cervical cancer vaccine for women who already have a significant presence of precancerous cells.

A complete map of gene expression for the worm may help address broad questions in neuroscience about how gene expression programs establish diverse sets of neurons and how genetic differences contribute to neuronal function in healthy and disease conditions.

Research led by Billy Hudson has identified an antibody associated with pulmonary-renal syndrome, a rare autoimmune condition.